ES2181771T3 - Composiciones de inhibina y metodo para el uso de la misma. - Google Patents
Composiciones de inhibina y metodo para el uso de la misma.Info
- Publication number
- ES2181771T3 ES2181771T3 ES95913576T ES95913576T ES2181771T3 ES 2181771 T3 ES2181771 T3 ES 2181771T3 ES 95913576 T ES95913576 T ES 95913576T ES 95913576 T ES95913576 T ES 95913576T ES 2181771 T3 ES2181771 T3 ES 2181771T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- heterological
- inhibine
- heterology
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- General Preparation And Processing Of Foods (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Preparations (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN METODO PARA ACELERAR LA APARICION DE LA PUBERTAD EN AVIARES, ESPECIALMENTE EN RATITAS Y PSITACIFORMES, MEDIANTE LA ADMINISTRACION DE UNA PROTEINA HETEROLOGA QUE CONTENGA INHIBINA, O UN FRAGMENTO DE LA MISMA, Y UNA PROTEINA DE SOPORTE. LA PRESENTE INVENCION TAMBIEN SE REFIERE A UN METODO PARA AUMENTAR LA PRODUCCION DE HUEVOS EN ANIMALES, EN PARTICULAR PAJAROS, PARTICULARMENTE RATITAS, MEDIANTE LA ADMINISTRACION DE LA PROTEINA HETEROLOGA. ESTA INVENCION TAMBIEN SE REFIERE A LA PROTEINA HETEROLOGA Y A UN METODO PARA LA PRODUCCION DE LA PROTEINA HETEROLOGA. LA PROTEINA HETEROLOGA PUEDE SER BIEN INHIBINA CONJUGADA A LA PROTEINA DE SOPORTE O INHIBINA FUSIONADA A LA PROTEINA DE SOPORTE. EL METODO PARA LA PRODUCCION DE LA PROTEINA HETEROLOGA FUSIONADA CONSISTE EN INSERTAR UNA INHIBINA QUE CODIFICA UN CADN DE DOBLE CEPA, O UN FRAGMENTO DE LA MISMA, EN UN VECTOR QUE CODIFICA UNA PROTEINA DE SOPORTE TAL COMO UNA PROTEINA QUE SE ENLAZA A LA MALTOSA O ALBUMINA DEL SUERO BOVINO. TRAS INSERTAR EL VECTOR EN UN SISTEMA DE EXPRESION, EL SISTEMA EXPRESA LA PROTEINA HETEROLOGA FUSIONADA. TRAS PURIFICAR LA PROTEINA HETEROLOGA EXPRESADA, SE ADMINISTRA UNA CANTIDAD EFECTIVA DE LA PROTEINA A UN ANIMAL DE MODO QUE SE PRODUZCA UNA RESPUESTA INMUNOLOGICA EN EL ANIMAL CONTRA LA PROTEINA HETEROLOGA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20296494A | 1994-02-28 | 1994-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2181771T3 true ES2181771T3 (es) | 2003-03-01 |
Family
ID=22751927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95913576T Expired - Lifetime ES2181771T3 (es) | 1994-02-28 | 1995-02-28 | Composiciones de inhibina y metodo para el uso de la misma. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0804219B1 (es) |
| JP (1) | JPH09510702A (es) |
| CN (1) | CN1149258A (es) |
| AT (1) | ATE220554T1 (es) |
| AU (1) | AU704737B2 (es) |
| BR (1) | BR9507426A (es) |
| CA (1) | CA2184183C (es) |
| DE (1) | DE69527439T2 (es) |
| DK (1) | DK0804219T3 (es) |
| ES (1) | ES2181771T3 (es) |
| FI (1) | FI963325A7 (es) |
| MX (1) | MX9603702A (es) |
| NO (1) | NO963572L (es) |
| NZ (1) | NZ282981A (es) |
| PL (1) | PL184202B1 (es) |
| PT (1) | PT804219E (es) |
| RU (1) | RU2170100C2 (es) |
| WO (1) | WO1995022980A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747659A (en) * | 1994-02-28 | 1998-05-05 | Agritech Technologies, Ltd. | Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein |
| US5786179A (en) * | 1994-02-28 | 1998-07-28 | Agritech Technologies Ltd. | Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same |
| WO2004043141A2 (en) * | 2002-11-07 | 2004-05-27 | Agritech Technology, Ltd | Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| ES2397113T3 (es) | 2005-06-23 | 2013-03-04 | Isis Pharmaceuticals, Inc. | Composiciones y procedimientos para modular el corte y empalme de SMN2 |
| US20090306347A1 (en) | 2005-08-29 | 2009-12-10 | Japan Science And Technology Agency | Antibody produced using ostrich and method for production thereof |
| CN115227709A (zh) | 2009-06-17 | 2022-10-25 | 冷泉港实验室 | 用于在对象中调节smn2剪接的组合物和方法 |
| WO2014110291A1 (en) | 2013-01-09 | 2014-07-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of smn2 splicing in a subject |
| BR102014005376A2 (pt) * | 2014-03-07 | 2016-02-10 | Ouro Fino Saúde Animal Ltda | antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica |
| MA39835A (fr) | 2014-04-17 | 2017-02-22 | Biogen Ma Inc | Compositions et procédés de modulation de l'épissage du smn2 chez un patient |
| WO2016040748A1 (en) | 2014-09-12 | 2016-03-17 | Ionis Pharmaceuticals, Inc. | Compositions and methods for detection of smn protein in a subject and treatment of a subject |
| WO2017218884A1 (en) | 2016-06-16 | 2017-12-21 | Ionis Pharmaceuticals, Inc. | Combinations for the modulation of smn expression |
| CN110551744A (zh) * | 2019-09-18 | 2019-12-10 | 普健生物（武汉）科技有限公司 | 一种人抑制素a的核苷酸序列及重组表达人抑制素a的方法 |
| PH12022552258A1 (en) | 2020-02-28 | 2023-11-20 | Ionis Pharmaceuticals Inc | Compounds and methods for modulating smn2 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089396A (en) * | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
-
1995
- 1995-02-28 PL PL95316628A patent/PL184202B1/pl not_active IP Right Cessation
- 1995-02-28 NZ NZ282981A patent/NZ282981A/en unknown
- 1995-02-28 AU AU20959/95A patent/AU704737B2/en not_active Ceased
- 1995-02-28 JP JP7522532A patent/JPH09510702A/ja not_active Withdrawn
- 1995-02-28 CN CN95192317A patent/CN1149258A/zh active Pending
- 1995-02-28 RU RU96119774/13A patent/RU2170100C2/ru not_active IP Right Cessation
- 1995-02-28 CA CA002184183A patent/CA2184183C/en not_active Expired - Fee Related
- 1995-02-28 BR BR9507426A patent/BR9507426A/pt not_active IP Right Cessation
- 1995-02-28 AT AT95913576T patent/ATE220554T1/de not_active IP Right Cessation
- 1995-02-28 ES ES95913576T patent/ES2181771T3/es not_active Expired - Lifetime
- 1995-02-28 FI FI963325A patent/FI963325A7/fi not_active Application Discontinuation
- 1995-02-28 MX MX9603702A patent/MX9603702A/es not_active IP Right Cessation
- 1995-02-28 WO PCT/US1995/002795 patent/WO1995022980A1/en not_active Ceased
- 1995-02-28 EP EP95913576A patent/EP0804219B1/en not_active Expired - Lifetime
- 1995-02-28 DE DE69527439T patent/DE69527439T2/de not_active Expired - Fee Related
- 1995-02-28 DK DK95913576T patent/DK0804219T3/da active
- 1995-02-28 PT PT95913576T patent/PT804219E/pt unknown
-
1996
- 1996-08-27 NO NO963572A patent/NO963572L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1149258A (zh) | 1997-05-07 |
| PT804219E (pt) | 2002-12-31 |
| RU2170100C2 (ru) | 2001-07-10 |
| DE69527439D1 (de) | 2002-08-22 |
| CA2184183C (en) | 2005-02-08 |
| CA2184183A1 (en) | 1995-08-31 |
| PL316628A1 (en) | 1997-02-03 |
| FI963325A0 (fi) | 1996-08-27 |
| NZ282981A (en) | 1998-08-26 |
| NO963572D0 (no) | 1996-08-27 |
| NO963572L (no) | 1996-10-25 |
| MX9603702A (es) | 1997-12-31 |
| ATE220554T1 (de) | 2002-08-15 |
| PL184202B1 (pl) | 2002-09-30 |
| WO1995022980A1 (en) | 1995-08-31 |
| FI963325L (fi) | 1996-10-21 |
| DK0804219T3 (da) | 2002-11-11 |
| BR9507426A (pt) | 1997-09-16 |
| EP0804219A1 (en) | 1997-11-05 |
| AU2095995A (en) | 1995-09-11 |
| FI963325A7 (fi) | 1996-10-21 |
| AU704737B2 (en) | 1999-05-06 |
| EP0804219A4 (en) | 1999-02-24 |
| EP0804219B1 (en) | 2002-07-17 |
| DE69527439T2 (de) | 2003-02-20 |
| JPH09510702A (ja) | 1997-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2074042T3 (es) | Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores. | |
| Ajioka et al. | Intracellular pools of transferrin receptors result from constitutive internalization of unoccupied receptors. | |
| BR9913433A (pt) | Sistema desinfetante estabilizado composto de duas partes e composições e métodos a ele relacionado | |
| BRPI0511755A (pt) | composições, fusões e conjugados de drogas e métodos de produção, tratamento e utilização | |
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| HRP20020787B1 (hr) | Postupak liječenja upotrebom kompleksa ligand-imunogen | |
| ES2177323T3 (es) | Preparaciones de insulina concentradas estables para la administracionpor via pulmonar. | |
| DK0971705T3 (da) | Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden | |
| ES2163444T3 (es) | Composiciones y metodos para la administracion oral de farmacos. | |
| BR9906903A (pt) | Composição com liberação sustentada, processos para produzir a mesma, para suprimir a brusca liberação inicial da susbtância bioativa de uma composição com liberação sustentada e para aumentar a eficiência da inclusão da substância bioativa em uma composição com liberação sustentada, produto farmacêutico, agente para prevenir ou tratar câncer prostático, hipertrofia prostática, endometriose, histeromioma, metrofibroma, puberdade precoce, dismenorréia, ou câncer do seio, ou um contraceptivo, e, composto | |
| ES2080838T3 (es) | Conjugados de anticuerpos especificos del receptor de transferrina y agentes neurofarmaceuticos. | |
| DK0742714T3 (da) | Flydende farmaceutiske præparater omfattende thyroideahormoner | |
| PE20050712A1 (es) | Anticuerpos rg1 | |
| BR9811094A (pt) | Agente terapêutico para tumores linfáticos | |
| ES2147924T3 (es) | Composicion terapeutica que comprende un antigeno o un generador in vivo de un compuesto que comprende una secuencia de aminoacidos. | |
| PT1272199E (pt) | Terapias de combinacao com actividade de lesao vascular | |
| DE69925371D1 (de) | Impfstoff für geflügel | |
| MX9603702A (es) | Composiciones de inhibina y métodos de uso en las mismas. | |
| DK1021534T3 (da) | Hepatitis C-receptorprotein CD81 | |
| ES2061521T3 (es) | Proteinas con actividad glutation-s-transferasa, secuencias de adn, anticuerpos, poxvirus y medicamentos para la prevencion de la equistosomiasis. | |
| EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
| JPS58501543A (ja) | ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良 | |
| AR133834A1 (es) | Agentes de penetración célular y sus usos | |
| CR10676A (es) | Agente para prevenir/ tratar el cancer | |
| MX9704879A (es) | Anticuerpo monoclonal novedoso que tiene actividad inhibidora contra fosfolipasa a2 de tipo ii y proteina que comprende una parte del mismo. |